Editorial: Ion Channels: Therapeutic Targets for Neurological Disease

The prevalence of most neurological disorders increases with age, and the lack of effective treatment options continues to increase the number of patients (Feigin et al., 2019). [...]developing new strategies to prevent and treat the major neurological disorders is of great importance to improve hum...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in molecular neuroscience Vol. 14; p. 797327
Main Authors Hou, Panpan, Du, Xiaona, An, Hailong
Format Journal Article
LanguageEnglish
Published Lausanne Frontiers Research Foundation 16.11.2021
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The prevalence of most neurological disorders increases with age, and the lack of effective treatment options continues to increase the number of patients (Feigin et al., 2019). [...]developing new strategies to prevent and treat the major neurological disorders is of great importance to improve human health. Dysfunction of ion channels by inherited mutations, pathological changes, or unwanted drug-induced side effects can alter ion flux across the membrane and cause neurological disorders. In this topic named “Ion Channels: Therapeutic Targets for Neurological Disease,” we collect and summarize the most recent studies including four original articles and two reviews focusing on ion channel modulation mechanisms and ion channels as potential targets for treating hearing loss, pain, spinal cord injury, ischemia-reperfusion injury, and schizophrenia. Unlike voltage-gated ion channels that sense the membrane voltage change via the voltage sensing domain (Wang et al., 2017; Hou et al., 2020), the transient receptor potential channels (TRP channels) are ligand-gated ion channels that are sensitive to physical (heat, pH, osmolarity, etc.) and chemical (ligands, Ca2+, etc.) stimuli from the environment, and therefore are important sensors for perception (Clapham, 2003).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
Edited and reviewed by: Jean-Marc Taymans, Institut National de la Santé et de la Recherche Médicale (INSERM), France
This article was submitted to Molecular Signalling and Pathways, a section of the journal Frontiers in Molecular Neuroscience
ISSN:1662-5099
1662-5099
DOI:10.3389/fnmol.2021.797327